Log in or Sign up for Free to view tailored content for your specialty!
Genetics/Genomics News
Top news of November: Semaglutide CV outcomes, treating statin intolerance and more
Healio and Cardiology Today have compiled a list of the most-read news in cardiology of November 2023.
News you may have missed from AHA 2023: SELECT, artificial intelligence, gene editing, more
Healio | Cardiology Today compiled a list of the top news from the 2023 American Heart Association Scientific Sessions.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Deepak L. Bhatt, MD, MPH, discusses gene editing, ORBITA-2, artificial intelligence
PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.
Early study suggests gene editing can lower LDL cholesterol via PCSK9 inhibition
PHILADELPHIA — A novel single-dose CRISPR base-editing infusion for patients with heterozygous familial hypercholesterolemia and advanced CAD reduced serum PCSK9 and lowered LDL by up to 55% in one patient, a speaker reported.
‘Engagement and discussion’ key themes of AHA’s annual Scientific Sessions
The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.
FDA approves Adzynma as first treatment for blood clotting disorder
The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults and pediatric patients with congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder.
Should athletes with genetic heart disease return to play after sudden cardiac arrest?
Recently, there have been a number of cases in which high-profile athletes have had sudden cardiac arrest due to a variety of causes.
‘One giant leap for HCM’: Gene therapy may reverse hypertrophic cardiomyopathy
Despite advances made for the treatment and management of hypertrophic cardiomyopathy, the condition remains a debilitating one for many patients, who are often undiagnosed until the disease has progressed.
Genetic predisposition to denture use linked to cardiometabolic disease
Genetic predisposition to denture use was associated with increased likelihood of cardiometabolic diseases and related risk factors including dyslipidemia and elevated waist circumference, researchers reported.
Lerodalcibep reduces LDL in well-treated patients with HeFH vs. placebo
Monthly lerodalcibep on top of maximum tolerated therapy reduced LDL an additional 60% over 24 weeks in patients with heterozygous familial hypercholesterolemia, with a safety profile similar vs. placebo, a speaker reported.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read